Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Quality Improvement Article
  • Published:

Development and implementation of restrictive platelet transfusion thresholds in a neonatal intensive care unit

Abstract

Objective

Thrombocytopenia is a common problem affecting preterm neonates. Recent studies show increased morbidity and mortality with liberal platelet transfusion thresholds. We sought to standardize thrombocytopenia management through a transfusion guideline to reduce excessive transfusions.

Study design

We developed and implemented a guideline using PDSA cycles for infants with birth weights <1000 grams. Platelet transfusions were classified as indicated or non-indicated per the guideline. Severe (grade 3 or 4) intraventricular hemorrhage and pulmonary hemorrhage rates were balancing measures.

Results

We analyzed 101 infants pre-guideline and 96 infants post-guideline. The mean monthly non-indicated transfusions significantly decreased from 13.0 to 2.0, respectively (p-value < 0.01). Incidence of severe grade IVH and pulmonary hemorrhage remained stable.

Conclusion

Rapid implementation of an evidence-based, restrictive platelet transfusion guideline significantly reduced non-indicated platelet transfusions without a concomitant increase in major bleeding events.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Finalized platelet transfusion guidelines flowchart. *Includes ELBWs; excludes ECMO patients.
Fig. 3: Control “p” chart of non-indicated transfusions.
Fig. 4: Pareto chart reveal the vital few and trivial few causes of non-compliance with the established guideline through the 80/20 rule.
Fig. 5: Balancing measures for major bleeding events.

Similar content being viewed by others

References

  1. Ghadeer HAA, Aldhahi RA, Dandan FKA, Alamer MH, Almulaifi LF, Muaibid AFA, et al. The prevalence and associated risk factors for neonatal thrombocytopenia among newborns admitted to the neonatal intensive care unit. Cureus. 2024;16:e56108.

    PubMed  PubMed Central  Google Scholar 

  2. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Sola-Visner MC, Lambert DK, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol. 2006;26:348–53.

    Article  CAS  PubMed  Google Scholar 

  3. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986;108:749–55.

    Article  CAS  PubMed  Google Scholar 

  4. Roberts I. Neonatal thrombocytopenia: causes and management. Arch Dis Child—Fetal Neonatal Ed. 2003;88:359F–364.

    Article  Google Scholar 

  5. Christensen RD, Baer VL, Henry E, Snow GL, Butler A, Sola-Visner MC. Thrombocytopenia in small-for-gestational-age infants. Pediatrics. 2015;136:e361.

    Article  PubMed  Google Scholar 

  6. Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380:242–51.

    Article  CAS  PubMed  Google Scholar 

  7. Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics. 2009;124:e826–34.

    Article  PubMed  Google Scholar 

  8. Moore CM, D’Amore A, Fustolo-Gunnink S, Hudson C, Newton A, Santamaria BL, et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2023;108:452.

    PubMed  Google Scholar 

  9. Bahr TM, Snow GL, Christensen TR, Davenport P, Henry E, Tweddell SM, et al. Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia? J Pediatr. 2024;265:113836.

    Article  CAS  PubMed  Google Scholar 

  10. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–34.

    Article  CAS  PubMed  Google Scholar 

  11. Montgomery DC. Statistical quality control: a modern introduction. 6th ed. Hoboken, NJ. John Wiley & Sons; 2010. p. 756.

  12. SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): Revised Publication Guidelines from a Detailed Consensus Process–PMC [Internet]. [cited 2024 Oct 21]. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4625997/

  13. Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol. 2001;21:415–20.

  14. Moore CM, O’Reilly D, McCallion N, Curley AE. Changes in inflammatory proteins following platelet transfusion in a neonatal population. Pediatr Res. 2023;94:1973–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Garraud O, Cognasse F, Tissot JD, Chavarin P, Laperche S, Morel P, et al. Improving platelet transfusion safety: biomedical and technical considerations. Blood Transfus. 2016;14:109–22.

    PubMed  PubMed Central  Google Scholar 

  16. Stolla M, Refaai MA, Heal JM, Spinelli SL, Garraud O, Phipps RP, et al. Platelet transfusion—the new immunology of an old therapy. Front Immunol. 2015;6:28.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sola-Visner M. Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology. 2012;2012:506–11.

    Article  PubMed  Google Scholar 

  18. So K, Fok T, Ng P, Wong W, Cheung K. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76:F43–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Shalish W, Olivier F, Aly H, Sant’Anna G. Uses and misuses of albumin during resuscitation and in the neonatal intensive care unit. Semin Fetal Neonatal Med. 2017;22:328–35.

    Article  PubMed  Google Scholar 

  20. Oca MJ, Nelson M, Donn SM. Randomized trial of normal saline versus 5% albumin for the treatment of neonatal hypotension. J Perinatol. 2003;23:473–6.

    Article  CAS  PubMed  Google Scholar 

  21. Emery EF, Greenough A, Gamsu HR. Randomised controlled trial of colloid infusions in hypotensive preterm infants. Arch Dis Child. 1992;67:1185–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bignall S, Bailey PC, Bass CA, Cramb R, Rivers RPA, Wadsworth J. The cardiovascular and oncotic effects of albumin infusion in premature infants. Early Hum Dev. 1989;20:191–201.

    Article  CAS  PubMed  Google Scholar 

  23. Davenport PE, Yuen JC, Briere J, Feldman HA, Sola-Visner MC, Leeman KT. Implementation of a neonatal platelet transfusion guideline to reduce non-indicated transfusions using a quality improvement framework. J Perinatol. 2021;41:1487.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bahr TM, Christensen TR, Henry E, Astin M, Ilstrup SJ, Ohls RK, et al. Platelet transfusions in a multi-neonatal intensive care unit health care organization before and after publication of the PlaNeT-2 clinical trial. J Pediatr. 2023;257:113388.

    Article  PubMed  Google Scholar 

  25. Chotas W, Wallman-Stokes A, Patel RM, Cooper C, Soll R. Platelet transfusion thresholds for thrombocytopenic infants. Cochrane Database Syst Rev. 2024;2024:CD015341.

    PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

NL, GP and AL all contributed to study design. NL and AB contributed to collection and assembly of data. NL completed analysis and interpretation of data. LV contributed to verification of quality improvement metrics. NL, GP, LV and AL contributed to manuscript preparation, writing, editing, and final approval.

Corresponding author

Correspondence to Natasha Lalos.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lalos, N., Brumfiel, A., Viehl, L.T. et al. Development and implementation of restrictive platelet transfusion thresholds in a neonatal intensive care unit. J Perinatol (2025). https://doi.org/10.1038/s41372-025-02302-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41372-025-02302-4

Search

Quick links